ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,464.62
      0.00%
      US Tech 100
      19,160.00
      -0.25%
      Dow Jones
      39,150.33
      0.00%
      Brent Oil
      84.525
      0.60%
      Bitcoin
      61,136.19
      -3.20%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Phathom Pharmaceuticals Inc (PHAT)

      7. Phathom Pharmaceuticals Inc (PHAT) Financials

      Phathom Pharmaceuticals Inc

      Phathom Pharmaceuticals Inc (PHAT)

      NASDAQ
      11.08
      -0.73
      (-6.18%)
      Closed June 21 4:00PM
      Delayed by 15 minutes
      11.08
      0.00
      ( 0.00% )
      Pre Market: 7:00AM
      Delayed by 15 minutes

      Phathom Pharmaceuticals Inc Financial Summary

      The current PHAT market cap is 648.57M. The company's latest EPS is USD -3.4439 and P/E is -3.22.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 000682k1.91M
      Operating Income -30.08M-31.7M-35.66M-69.88M-69.95M
      Net Income -37.81M-40.97M-43.24M-79.57M-82.85M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 0000682k
      Operating Income -106.22M-125.67M-135.08M-172.44M-167.31M
      Net Income -255.13M-129.07M-143.88M-197.72M-201.59M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 144.01M265.04M236.99M413.84M356.5M
      Total Liabilities 234.21M247.44M254.77M486.6M505M
      Total Equity -90.2M17.6M-17.77M-72.76M-148.5M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 257.18M295.11M189.43M164.81M413.84M
      Total Liabilities 29.22M100.84M117.28M239.62M486.6M
      Total Equity 227.96M194.27M72.16M-74.81M-72.76M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -39.67M-61.87M-93.78M-137.58M-69.02M
      Investing -214k-220k-1.16M-1.63M-40k
      Financing 14.07M155.57M155.59M367.58M9.9M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -36.51M-69.69M-148.62M-146.53M-137.58M
      Investing -25.25M-1.04M-328k-1.04M-1.63M
      Financing 304.65M114.46M44.71M120.04M367.58M

      Stats and Ratios

      Market Cap 648.57M
      Price to Earnings Ratio -3.22
      Price to Sales Ratio 947.01
      Price to Cash Ratio 1.7
      Price to Book Ratio -8.91
      Dividend Yield -

      Share Statistics

      Shares Outstanding 58.54M
      Average Volume (1 week) 0
      Average Volume (1 Month) 0
      52 Week Change -
      52 Week High -
      52 Week Low -
      Spread (Intraday) 0.72 (6.22%)

      Company Info

      Company Name Phathom Pharmaceuticals Inc
      Address 251 little falls drive
      wilmington, delaware 19808
      Website https://www.phathompharma.com
      Industry pharmaceutical preparations (2834)